- BreakBio AI analyzes cancer cells from each patient to find not one, but many proteins on them
- AI training repeated for patient from innovative, unique mass spectrometry analysis of each patient's cancer cells
- Dawn of AI drug design per patient
- BreakBio manufactures the drugs: synthetic copies of these proteins, the dawn of personalized drug manufacture
Our mission is a breakthrough in the treatment and cure of all solid cancers. BreakBio is named for this vision a Breakthrough in Biotech. Our first aim is to quickly achieve Breakthrough Therapy Designation from the FDA for our first cancer indication.
